FDA Inspection 1305632 — Merck & Co. Inc
The FDA completed an inspection of Merck & Co. Inc on Mar 13, 2026 in Rahway, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 13, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rahway, NJ (United States)